A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer's models.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Brain, behavior, and immunity

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbi.2017.08.019PMID 28860067PMCID PMC5865478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.

  2017cited by this paper
• Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes

  2017cited by this paper
• Osteopontin regulates macrophage activation and osteoclast formation in hypertensive patients with vascular calcification

  2017cited by this paper
• Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.

  2017cited by this paper
• Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.

  2017cited by this paper
• Individual estimates of age at detectable amyloid onset for risk factor assessment

  2016cited by this paper
• Protective features of peripheral monocytes/macrophages in stroke.

  2016cited by this paper
• The Cellular Phase of Alzheimer's Disease.

  2016cited by this paper
• Ocular indicators of Alzheimer’s: exploring disease in the retina

  2016cited by this paper
• Osteopontin Deficiency Accelerates Spontaneous Colitis in Mice with Disrupted Gut Microbiota and Macrophage Phagocytic Activity

  2015influential reference
• Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer’s disease–like mice

  2015cited by this paper
• Melanopsin retinal ganglion cell loss in Alzheimer disease

  2015cited by this paper
• Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer’s disease

  2015cited by this paper
• Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.

  2015influential reference
• Macrophage‐derived osteopontin induces reactive astrocyte polarization and promotes re‐establishment of the blood brain barrier after ischemic stroke

  2015cited by this paper
• Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.

  2014influential reference
• Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes

  2014cited by this paper
• The effect of osteopontin and osteopontin-derived peptides on preterm brain injury

  2014cited by this paper
• Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury.

  2014influential reference
• Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage

  2013cited by this paper
• Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer's Disease

  2013cited by this paper
• Modulation of macrophage phenotype by cell shape

  2013cited by this paper
• Osteopontin alters the functional profile of porcine microglia in vitro

  2012cited by this paper
• Osteopontin: A key link between immunity, inflammation and the central nervous system

  2012cited by this paper
• Animal Models of Alzheimer’s Disease: Utilization of Transgenic Alzheimer’s Disease Models in Studies of Amyloid Beta Clearance

  2012influential reference
• Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where.

  2012cited by this paper
• Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

  2012cited by this paper
• Osteopontin in macrophage function

  2011influential reference
• Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.

  2011cited by this paper
• Osteopontin Enhances Endogenous Repair After Neonatal Hypoxic–Ischemic Brain Injury

  2011cited by this paper
• Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer's disease.

  2011influential reference
• Osteopontin: Correlation with phagocytosis by brain macrophages in a rat model of stroke

  2011influential reference
• Trafficking CD11b-Positive Blood Cells Deliver Therapeutic Genes to the Brain of Amyloid-Depositing Transgenic Mice

  2010influential reference
• Protective effects of recombinant osteopontin on early brain injury after subarachnoid hemorrhage in rats*

  2010cited by this paper
• Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

  2010cited by this paper
• Osteopontin is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease and Its Levels Correlate with Cognitive Decline

  2010cited by this paper
• Infiltrating Blood-Derived Macrophages Are Vital Cells Playing an Anti-inflammatory Role in Recovery from Spinal Cord Injury in Mice

  2009cited by this paper
• Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

  2009cited by this paper
• The role of osteopontin in inflammatory processes

  2009cited by this paper
• Attenuation of AD‐like neuropathology by harnessing peripheral immune cells: local elevation of IL‐10 and MMP‐9

  2009influential reference
• Osteopontin Enhances Phagocytosis through a Novel Osteopontin Receptor, the αXβ2 Integrin1

  2009influential reference
• Degradation of fibrillar forms of Alzheimer’s amyloid β-peptide by macrophages

  2008cited by this paper
• Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

  2008cited by this paper
• Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages.

  2008cited by this paper
• Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

  2007influential reference
• Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease

  2007influential reference
• Transient microglial and prolonged astroglial upregulation of osteopontin following transient forebrain ischemia in rats.

  2007cited by this paper
• Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain.

  2007cited by this paper
• Selective ablation of bone marrow‐derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model

  2007influential reference
• Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.

  2006cited by this paper
• Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1.

  2006influential reference
• Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.

  2006cited by this paper
• Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

  2006cited by this paper
• Mechanism of Cerebral β‐Amyloid Angiopathy: Murine and Cellular Models

  2006cited by this paper
• Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease.

  2005cited by this paper
• Neuroprotection by Osteopontin in Stroke

  2005cited by this paper
• Expression of osteopontin and its ligand, CD44, in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis.

  2004cited by this paper
• Osteopontin synthesis and localization along the human nephron.

  2002cited by this paper
• Osteopontin, a Novel Substrate for Matrix Metalloproteinase-3 (Stromelysin-1) and Matrix Metalloproteinase-7 (Matrilysin)*

  2001cited by this paper
• TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

  2001cited by this paper
• Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein

  2001cited by this paper
• Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid.

  1998cited by this paper
• Alzheimer’s Disease as Proteolytic Disorders: Anabolism and Catabolism of β-Amyloid

  1998cited by this paper
• Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau

  1998cited by this paper
• Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease

  1996cited by this paper
• Brefeldin A inhibits the formation of constitutive secretory vesicles and immature secretory granules from the trans-Golgi network.

  1992cited by this paper
• Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection

  1989cited by this paper
• Isolation and characterization of two sialoproteins present only in bone calcified matrix.

  1985cited by this paper
• The amyloid deposits in Alzheimer's disease: their nature and pathogenesis.

  1984cited by this paper

• Deficiency of Microglial‐Derived Spp1 Exacerbates Age‐Related Memory Decline by Impairing Mitochondrial Complex I Function

  2026cites this paper
• Effects of Osteopontin Combined with Milk Fat Globule Membrane Proteins on Scopolamine-Induced Learning and Memory Impairment in Mice

  2025cites this paper
• Astrocyte cell-surface proteomics identified CD44 as an OPN/SPP1 receptor regulating lipid metabolism and glial crosstalk in Alzheimer’s disease

  2025cites this paper
• JNK Signaling Pathway Activity Alterations in the Rat Hippocampus: Effect of Age, Alzheimer’s Disease-Like Pathology Development, and the JNK Inhibitor IQ-1S

  2025cites this paper
• New Research on Biomarkers in Alzheimer's Continuum.

  2025cites this paper
• Osteopontin in Alzheimer's Disease: A Double‐Edged Sword in Neurodegeneration and Neuroprotection—A Systematic Review

  2025cites this paper
• The role of monocytes and macrophages in the progression of Alzheimer’s disease

  2025cites this paper
• Bone-derived factors mediate crosstalk between skeletal and extra-skeletal organs

  2025cites this paper
• Alzheimer’s disease risk factor APOE4 exerts dimorphic effects on female bone

  2025cites this paper
• Single-Cell Transcriptomic Analysis Reveals Cell Heterogeneity and Altered Signaling Pathways in Jellyfish Sting Patients

  2025cites this paper
• The brain–bone axis: unraveling the complex interplay between the central nervous system and skeletal metabolism

  2024cites this paper
• New preclinical biomarkers for prion diseases in the cerebrospinal fluid proteome revealed by mass spectrometry

  2024cites this paper
• Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders

  2024cites this paper
• Border-associated macrophages: From physiology to therapeutic targets in Alzheimer's disease.

  2024cites this paper
• Blockade of brain alkaline phosphatase efficiently reduces amyloid-β plaque burden and associated cognitive impairment

  2024cites this paper
• The Role of Osteopontin (OPN) in Regulating Microglia Phagocytosis in Nervous System Diseases.

  2024cites this paper
• Matricellular proteins: From cardiac homeostasis to immune regulation.

  2024cites this paper
• Exploring resveratrol against Alzheimer's disease and Parkinson's disease through integrating network pharmacology, bioinformatics, and experimental validation strategy in vitro

  2024cites this paper
• Osteopontin: A novel marker of pre‐symptomatic sporadic Alzheimer's disease

  2024cites this paper
• Single-cell RNA sequencing reveals the evolution of the immune landscape during perihematomal edema progression after intracerebral hemorrhage

  2024cites this paper
• Research progress in Alzheimer's disease and bone-brain axis.

  2024cites this paper
• Chlamydia pneumoniae in Alzheimer's disease pathology

  2024cites this paper
• Enhancing sciatic nerve regeneration with osteopontin-loaded acellular nerve allografts in rats: Effects on macrophage polarization.

  2024cites this paper
• Osteopontin drives neuroinflammation and cell loss in MAPT-N279K frontotemporal dementia patient neurons.

  2024cites this paper
• Microglia pack a toolbox for life.

  2024cites this paper
• Microglial- neuronal crosstalk in chronic viral infection through mTOR, SPP1/OPN and inflammasome pathway signaling

  2024cites this paper
• Treatment with glatiramer acetate in APPswe/PS1dE9 mice at an early stage of Alzheimer’s disease prior to amyloid-beta deposition delays the disease’s pathological development and ameliorates cognitive decline

  2024cites this paper
• Microglia maintain structural integrity during fetal brain morphogenesis

  2024cites this paper
• Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer’s disease

  2023cites this paper
• Recruitment mechanisms and therapeutic implications of tumor-associated macrophages in the glioma microenvironment

  2023cites this paper
• NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases

  2023cites this paper
• Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease

  2023influential citation
• Exercise Intervention for Alzheimer’s Disease: Unraveling Neurobiological Mechanisms and Assessing Effects

  2023influential citation
• Effects of anti‐tau immunotherapy on reactive microgliosis, cerebral endotheliopathy, and cognitive function in an experimental model of cerebral malaria

  2023cites this paper
• Immune-related signature of periodontitis and Alzheimer’s disease linkage

  2023cites this paper
• Immunization with Neural-Derived Peptides in Neurodegenerative Diseases: A Narrative Review

  2023cites this paper
• Associations of cortical SPP1 and ITGAX with cognition and common neuropathologies in older adults

  2023cites this paper
• Urinary SPP1 has potential as a non‐invasive diagnostic marker for focal segmental glomerulosclerosis

  2023cites this paper
• Genetic analysis of potential biomarkers and therapeutic targets in neuroinflammation from sporadic Creutzfeldt–Jakob disease

  2023cites this paper
• Inconsistent Effects of Glatiramer Acetate Treatment in the 5xFAD Mouse Model of Alzheimer’s Disease

  2023cites this paper
• Two different isoforms of osteopontin modulate myelination and axonal integrity

  2023cites this paper
• Targeting aging with the healthy skeletal system: The endocrine role of bone

  2023cites this paper
• NOX4 as a critical effector mediating neuroinflammatory cytokines, myeloperoxidase and osteopontin, specifically in astrocytes in the hippocampus in Parkinson's disease.

  2023cites this paper
• The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer’s-related disease and preserving cognition

  2023cites this paper
• Osteopontin depletion in macrophages perturbs proteostasis via regulating UCHL1-UPS axis and mitochondria-mediated apoptosis

  2023cites this paper
• Localized microglia dysregulation impairs central nervous system myelination in development

  2023cites this paper
• Mechanistic Insights into the Role of OPN in Mediating Brain Damage via Triggering Lysosomal Damage in Microglia/Macrophage

  2023cites this paper
• Alteration of the MEK1/2–ERK1/2 Signaling Pathway in the Retina Associated with Age and Development of AMD-Like Retinopathy

  2023cites this paper
• Loss of the m6A methyltransferase METTL3 in monocyte-derived macrophages ameliorates Alzheimer’s disease pathology in mice

  2023cites this paper
• Alteration of the MEK1/2–ERK1/2 signaling pathway in the retina with age and with the development of amd-like retinopathy

  2023cites this paper
• Myeloid Cells As a Promising Target for Brain–Bone Degenerative Diseases from a Metabolic Point of View

  2023cites this paper
• ASSESSMENT OF THE CONDITION OF THE ORAL CAVITY IN EARLY DIAGNOSIS OF COGNITIVE DEFICITS

  2022cites this paper
• A Mutant Variant of E2F4 Triggers Multifactorial Therapeutic Effects in 5xFAD Mice

  2022cites this paper
• Altered Glymphatic System in Middle-Aged cART-Treated Patients With HIV: A Diffusion Tensor Imaging Study

  2022cites this paper
• The Role of Osteopontin in Microglia Biology: Current Concepts and Future Perspectives

  2022cites this paper
• Perivascular SPP1 Mediates Microglial Engulfment of Synapses in Alzheimer’s Disease Models

  2022cites this paper
• The Emerging Evidence for a Protective Role of Fucoidan from Laminaria japonica in Chronic Kidney Disease-Triggered Cognitive Dysfunction

  2022cites this paper
• The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases

  2022cites this paper
• Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation

  2022cites this paper
• Identification of Biomarkers Related to M2 Macrophage Infiltration in Alzheimer’s Disease

  2022cites this paper
• Potential Progression Mechanism and Key Genes in Early Stage of mTBI

  2022cites this paper
• Inhibiting vascular smooth muscle cell proliferation mediated by osteopontin via regulating gut microbial lipopolysaccharide: A novel mechanism for paeonol in atherosclerosis treatment

  2022cites this paper
• Maternal immune activation alters fetal and neonatal microglia phenotype and disrupts neurogenesis in mice

  2022cites this paper
• Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer’s-induced retinal vasculopathy by limiting Clec7a/Galectin-3+ neurodegenerative microglia

  2022cites this paper
• Osteopontin - The stirring multifunctional regulatory factor in multisystem aging

  2022cites this paper
• Bioinformatics and System Biology Techniques to Determine Biomolecular Signatures and Pathways of Prion Disorder

  2022cites this paper
• Bone-Derived Factors as Potential Biomarkers for Parkinson’s Disease

  2021cites this paper
• Endocrine Regulation of Extra-skeletal Organs by Bone-derived Secreted Protein and the effect of Mechanical Stimulation

  2021cites this paper
• Identification of Hub Genes in Patients with Alzheimer Disease and Obstructive Sleep Apnea Syndrome Using Integrated Bioinformatics Analysis

  2021cites this paper
• Comparative Review of Microglia and Monocytes in CNS Phagocytosis

  2021cites this paper
• Evaluating Effects of Glatiramer Acetate Treatment on Amyloid Deposition and Tau Phosphorylation in the 3xTg Mouse Model of Alzheimer’s Disease

  2021cites this paper
• Retinal Vasculopathy in Alzheimer’s Disease

  2021cites this paper
• Immunomodulation induced by central nervous system‐related peptides as a therapeutic strategy for neurodegenerative disorders

  2021cites this paper
• Intranasal Delivery of RGD-Containing Osteopontin Heptamer Peptide Confers Neuroprotection in the Ischemic Brain and Augments Microglia M2 Polarization

  2021cites this paper
• Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology

  2021cites this paper
• MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer’s Disease: A Study in Senescence-Accelerated OXYS Rats

  2021cites this paper
• Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy

  2021cites this paper
• Bone-Derived Modulators That Regulate Brain Function: Emerging Therapeutic Targets for Neurological Disorders

  2021cites this paper
• Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke.

  2021cites this paper
• Alzheimer’s Retinopathy: Seeing Disease in the Eyes

  2020cites this paper
• Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances.

  2020cites this paper
• Analysis of Six Bone-Derived Factors in Plasma and CSF of Chinese Patients with Parkinson's Disease

  2020cites this paper
• Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment

  2020cites this paper
• Regional Differences in Neuroinflammation-Associated Gene Expression in the Brain of Sporadic Creutzfeldt–Jakob Disease Patients

  2020cites this paper
• Genetic knockdown of Klk8 has sex‐specific multi‐targeted therapeutic effects on Alzheimer’s pathology in mice

  2020cites this paper
• Regulatory Roles of Bone in Neurodegenerative Diseases

  2020cites this paper
• Dying neurons conduct repair processes in the injured brain through osteopontin expression in cooperation with infiltrated blood monocytes

  2020influential citation
• MSCs-extracellular vesicles attenuated neuroinflammation, synapse damage and microglial phagocytosis after hypoxia-ischemic injury by preventing osteopontin expression.

  2020cites this paper
• The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease

  2020cites this paper
• The Yin-Yang of osteopontin in nervous system diseases: damage versus repair

  2020influential citation
• Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease

  2020cites this paper
• Parallels between retinal and brain pathology and response to immunotherapy in old, late‐stage Alzheimer's disease mouse models

  2020cites this paper
• Biomarkers for Alzheimer’s Disease Early Diagnosis

  2020cites this paper
• Effects of IL-34 on Macrophage Immunological Profile in Response to Alzheimer's-Related Aβ42 Assemblies

  2020influential citation
• Patterns of Osteopontin Expression in Abusive Head Trauma Compared With Other Causes of Pediatric Traumatic Brain Injury.

  2020cites this paper
• Quantitative proteomic analysis of the frontal cortex in Alzheimer’s disease

  2020cites this paper
• E2F4 as a single multifactorial target against Alzheimer’s disease

  2020cites this paper
• Advances in Retinal Imaging: Retinal Amyloid Imaging

  2020cites this paper
• Osteopontin heptamer peptide containing the RGD motif enhances the phagocytic function of microglia.

  2020cites this paper
• Activated Bone Marrow-Derived Macrophages Eradicate Alzheimer's-Related Aβ42 Oligomers and Protect Synapses

  2020cites this paper